ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,144Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 5176

$1.03M Total Retail Price of All Prescriptions

Rank: 241 out of 5176

924 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 924 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 924 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 13,175 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,001 777 1 1
AMLODIPINE BESYLATE 789 700 2 2
METOPROLOL TARTRATE 704 592 3 6
LEVOTHYROXINE SODIUM 554 422 4 4
LISINOPRIL 541 429 5 5
OMEPRAZOLE 534 372 6 3
FUROSEMIDE 459 373 7 8
ATORVASTATIN CALCIUM 400 361 8 9
CRESTOR 358 241 9 15
LOSARTAN POTASSIUM 298 270 10 14
ATENOLOL 246 164 11 12
LOVASTATIN 240 182 12 46
METOPROLOL SUCCINATE 240 203 12 11
WARFARIN SODIUM 227 199 14 13
METFORMIN HCL 227 188 14 7
DIOVAN HCT 226 152 16 39
HYDROCODONE-ACETAMINOPHEN 219 130 S3 17 27
DIOVAN 205 170 18 19
GLIPIZIDE ER 190 163 19 117
GABAPENTIN 182 131 20 21
LOSARTAN-HYDROCHLOROTHIAZIDE 177 149 21 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 142 22 49
ALENDRONATE SODIUM 162 146 23 18
ALLOPURINOL 160 110 24 41
AZITHROMYCIN 148 103 25 42
HYDROCHLOROTHIAZIDE 147 98 26 10
CITALOPRAM HBR 140 91 27 31
SPIRIVA 140 133 27 54
SERTRALINE HCL 136 101 29 30
PAROXETINE HCL 132 79 30 93
GLYBURIDE-METFORMIN HCL 126 86 R 31 76
POTASSIUM CHLORIDE 124 107 32 34
GLIPIZIDE XL 123 110 33 83
VENTOLIN HFA 122 70 34 64
OXYCODONE-ACETAMINOPHEN 111 97 S2 35 101
CLOPIDOGREL 108 91 36 26
BYSTOLIC 104 103 37 96
PANTOPRAZOLE SODIUM 104 76 37 61
METFORMIN HCL ER 104 94 37 57
PREDNISONE 103 82 40 52
TAMSULOSIN HCL 103 88 40 20
DONEPEZIL HCL 101 101 42 28
RANITIDINE HCL 96 64 43 36
ZOLPIDEM TARTRATE 92 52 44 17
DIGOXIN 92 71 44 56
GLYBURIDE 87 63 R 46 67
AMLODIPINE BESYLATE-BENAZEPRIL 83 71 47 55
SYNTHROID 83 71 47 33
FLUTICASONE PROPIONATE 82 25 49 38
ADVAIR DISKUS 81 60 50 32
PEN NEEDLE 79 48 51 144
PLAVIX 77 59 52 29
IBUPROFEN 76 31 53 72
LABETALOL HCL 75 47 54 114
MELOXICAM 75 65 54 53
ACETAMINOPHEN-CODEINE 74 70 S3 56 127
TRIAMTERENE-HCTZ 73 48 57 86
NEXIUM 72 21 58 16
AMOXICILLIN 71 53 59 163
LEVEMIR FLEXPEN 70 45 60 200
VERAPAMIL ER 70 70 60 155
SYMBICORT 67 56 62 120
RAMIPRIL 65 53 63 50
FLUOXETINE HCL 65 59 63 132
ISOSORBIDE MONONITRATE ER 63 63 65 44
COMBIVENT 63 34 65 156
DILTIAZEM 24HR ER 60 38 67 136
CYCLOBENZAPRINE HCL 59 30 R 68 143
TERAZOSIN HCL 58 58 69 158
PROPRANOLOL HCL 57 46 70 199
CARVEDILOL 56 44 71 24
PROAIR HFA 56 21 71 60
PRAVASTATIN SODIUM 56 44 71 23
FINASTERIDE 56 47 71 69
LIPITOR 55 38 75 51
INSULIN SYRINGE 55 35 75 137
AZOR 55 54 75 194
AMITRIPTYLINE HCL 55 29 R 75 177
LANSOPRAZOLE 55 49 75 113
NOVOLOG MIX 70-30 FLEXPEN 54 46 80 290
VALSARTAN-HYDROCHLOROTHIAZIDE 53 42 81 292
GLIPIZIDE 53 53 81 63
TRAZODONE HCL 50 34 83 71
ACTONEL 50 50 83 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.